# Takeda Pharmaceutical Company Limited (NYSE: TAK), Round Lake, IL – FDA Inspections

Source: https://www.keypedia.com/companies/takeda-pharmaceutical-company-limited/4611dabc-52f7-4b4a-96bf-4196e34a7c2b

> Inspection records and compliance data for Takeda Pharmaceutical Company Limited in Round Lake, Illinois. 3 FDA inspections on record, 2 Form 483s, last inspected November 26, 2025. Publicly traded as NYSE: TAK.

---

## Details

- Name: Takeda Pharmaceutical Company Limited
- FEI Number: 3012385969
- Address Line 1: 25212 W Il Route 120
- City: Round Lake
- State: Illinois
- Zip Code: 60073
- Country Name: United States
- Address: 25212 W Il Route 120, Round Lake, Illinois 60073, United States
- Country: United States

## Stock

- Stock ticker: TAK
- Exchange: NYSE
- Share price: $21.13
- Market cap: $66.8B
- Price as of: November 13, 2026

## Related Documents

- [483 - Takeda Pharmaceutical Company Limited - 2025-11-26](https://www.keypedia.com/records/483/takeda-pharmaceutical-company-limited/e314f461-7a2b-42e9-9181-710be64dee9c) — source: FDA, date: November 26, 2025
- [FDA Inspection 1293098 - Takeda Pharmaceutical Company Limited - 2025-11-26](https://www.keypedia.com/records/fda_inspections/takeda-pharmaceutical-company-limited/1a77ba55-396a-4912-81d2-ff91a8e53f0c) — source: FDA, date: November 26, 2025
- [483 - Takeda Pharmaceutical Company Limited - 2022-09-15](https://www.keypedia.com/records/483/takeda-pharmaceutical-company-limited/4e49acd1-ce68-49ee-bfe4-8266281bdf7c) — source: FDA, date: September 15, 2022
- FDA Inspection 1179911 - Takeda Pharmaceutical Company Limited - 2022-09-15 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 15, 2022
- FDA Inspection 1179911 - Takeda Pharmaceutical Company Limited - 2022-09-15 — classification: No Action Indicated (NAI), source: FDA, date: September 15, 2022
- [FDA Inspection 1103189 - Takeda Pharmaceutical Company Limited - 2019-09-25](https://www.keypedia.com/records/fda_inspections/takeda-pharmaceutical-company-limited/f815b5da-2d6a-4e03-8688-006a8fbebf36) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 25, 2019

## Related Companies

- [Humacyte Global Inc](https://www.keypedia.com/companies/humacyte-global-inc/74158903-037d-4b32-a3b5-6c90f73f3f1f)
- [Kamada - Production Plant](https://www.keypedia.com/companies/kamada-production-plant/d3a7a962-b08c-4278-8951-5cad5bcfed41)
- [Dendreon Pharmaceuticals LLC](https://www.keypedia.com/companies/dendreon-pharmaceuticals-llc/68ccd67e-0a3a-41cb-ae30-e9e10a6eaef5)
- [MassBiologics](https://www.keypedia.com/companies/massbiologics/fa584e7c-22de-470c-836a-dd3028fae600)
- [LifeSouth Community Blood Centers, Inc](https://www.keypedia.com/companies/lifesouth-community-blood-centers-inc/94ebe4e9-b648-4d51-a063-4ad00b617893)
- [Regenerative Processing Plant, LLC](https://www.keypedia.com/companies/regenerative-processing-plant-llc/9460f9cb-85fa-400b-9e07-36e5b2a73133)
- [Rovi Pharma Industrial Services S.A.](https://www.keypedia.com/companies/rovi-pharma-industrial-services-sa/947a0616-87f8-4886-a6c2-278c5e678192)
- [Baxalta US Inc.](https://www.keypedia.com/companies/baxalta-us-inc/dd00e45b-9175-4b17-82d5-b189a034a97f)
- [Seqirus Inc](https://www.keypedia.com/companies/seqirus-inc/0debebe6-6f57-40d3-abf9-5914fb18b58a)
- [GlaxoSmithKline Biologicals](https://www.keypedia.com/companies/glaxosmithkline-biologicals/98ade6fb-8ae1-48af-a7cf-71b26cd2e808)

## Related Officers

- [CO CDER OMQ](https://www.keypedia.com/people/claire-m-minden/26e33375-abfd-4e2e-8eef-5ae8b60425f1)
- [Peng Zhou](https://www.keypedia.com/people/peng-zhou/ce413ab5-8787-4012-bc8f-9ef55f2c3dc1)
- [Investigator](https://www.keypedia.com/people/shafiq-s-ahadi/dd146b0a-ca1c-4052-8f50-4d68e14ad73f)
